Point72 Asset Management
CLB icon

Point72 Asset Management’s Core Laboratories CLB Stock Holding History

Point72 Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-71,735
Closed -$887K – 3933
2025
Q3 		$887K Buy
71,735
+9,435
+15% +$111K ﹤0.01% 1740
2025
Q2 		$718K Buy
+62,300
New +$739K ﹤0.01% 1671
2025
Q1 		– Sell
-15,344
Closed -$266K – 2100
2024
Q4 		$266K Buy
+15,344
New +$296K ﹤0.01% 1821
2019
Q3 		– Sell
-4,615
Closed -$241K – 1171
2019
Q2 		$241K Buy
+4,615
New +$271K ﹤0.01% 943
2016
Q2 		– Sell
-5,000
Closed -$562K – 736
2016
Q1 		$562K Buy
+5,000
New +$519K ﹤0.01% 654
2015
Q4 		– Sell
-11,932
Closed -$1.19M – 696
2015
Q3 		$1.19M Buy
+11,932
New +$1.3M 0.01% 608

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management's CLB Position: Q4 2025 in Review

Point72 Asset Management sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 71,735 shares — an estimated $887K sold.

Point72 Asset Management first reported a position in CLB in Q3 2015 and held it in 6 quarters. The position peaked at $1.19M in Q3 2015. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

  • Point72 Asset Management reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 71,735 Core Laboratories shares in Q4 2025, an estimated $887K.
  • Point72 Asset Management first reported a position in Core Laboratories in Q3 2015 and held it in 6 quarters.
  • Point72 Asset Management's Core Laboratories position peaked at $1.19M in Q3 2015.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.